Standard Biotools (LAB) Acquisitions (2014 - 2024)
Standard Biotools' (LAB) quarterly Acquisitions came in at $280.0 million in Q1 2024, up 5333.31% quarter-over-quarter from $5.2 million in Q1 2020.
Powered by 
Analysis
Standard Biotools (LAB) Acquisitions (2014 - 2024) Analysis & Trends
Standard Biotools (LAB) has reported Acquisitions for 3 consecutive years, with $280.0 million the latest figure, recorded in Q1 2024.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $280.0 million in Q1 2024; TTM through Dec 2024 was $280.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $280.0 million, changed N/A from the prior year.
- Acquisitions was $280.0 million for Q1 2024 at Standard Biotools, up from $5.2 million in the prior quarter.
- Over five years, Acquisitions peaked at $280.0 million in Q1 2024 and troughed at $5.2 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | - |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 950.00 Mn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 2.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | - |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 280.03 Mn |
| Mar 31, 2020 | 5.15 Mn |
| Mar 31, 2014 | 113.19 Mn |